Literature DB >> 27921303

Eosinophils from eosinophilic oesophagitis patients have T cell suppressive capacity and express FOXP3.

C Lingblom1, J Wallander1, M Ingelsten1, H Bergquist2, M Bove3, R Saalman4, A Welin5, C Wennerås1.   

Abstract

Eosinophilic esophagitis (EoE) is an antigen-driven T cell-mediated chronic inflammatory disease where food and environmental antigens are thought to have a role. Human eosinophils express the immunoregulatory protein galectin-10 and have T cell suppressive capacity similar to regulatory T cells (Tregs ). We hypothesized that one function of eosinophils in EoE might be to regulate the T cell-driven inflammation in the oesophagus. This was tested by evaluating the suppressive capacity of eosinophils isolated from the blood of adult EoE patients in a mixed lymphocyte reaction. In addition, eosinophilic expression of forkhead box protein 3 (FOXP3), the canonical transcription factor of Tregs , was determined by conventional and imaging flow cytometry, quantitative polymerase chain reaction (qPCR), confocal microscopy and immunoblotting. It was found that blood eosinophils from EoE patients had T cell suppressive capacity, and that a fraction of the eosinophils expressed FOXP3. A comparison of EoE eosinophils with healthy control eosinophils indicated that the patients' eosinophils had inferior suppressive capacity. Furthermore, a higher percentage of the EoE eosinophils expressed FOXP3 protein compared with the healthy eosinophils, and they also had higher FOXP3 protein and mRNA levels. FOXP3 was found in the cytosol and nucleus of the eosinophils from both the patients and healthy individuals, contrasting with the strict nuclear localization of FOXP3 in Tregs . To conclude, these findings suggest that the immunoregulatory function of eosinophils may be impaired in EoE.
© 2016 British Society for Immunology.

Entities:  

Keywords:  FOXP3; eosinophilic esophagitis; eosinophils; regulatory T cells; suppression

Mesh:

Substances:

Year:  2016        PMID: 27921303      PMCID: PMC5290232          DOI: 10.1111/cei.12898

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Relative lack of T regulatory cells in adult eosinophilic esophagitis - no normalization after corticosteroid therapy.

Authors:  M C Stuck; A Straumann; H-U Simon
Journal:  Allergy       Date:  2010-12-08       Impact factor: 13.146

2.  Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice.

Authors:  Anil Mishra; James Schlotman; Meiqin Wang; Marc E Rothenberg
Journal:  J Leukoc Biol       Date:  2006-12-28       Impact factor: 4.962

3.  Association of eosinophilic inflammation with esophageal food impaction in adults.

Authors:  Tusar K Desai; Veslav Stecevic; Chung-Ho Chang; Neal S Goldstein; Kamran Badizadegan; Glenn T Furuta
Journal:  Gastrointest Endosc       Date:  2005-06       Impact factor: 9.427

4.  Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase.

Authors:  Solomon O Odemuyiwa; Ahmad Ghahary; Yunyuan Li; Lakshmi Puttagunta; Joo Eun Lee; Sorin Musat-Marcu; Aziz Ghahary; Redwan Moqbel
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

5.  Genome-wide identification of human FOXP3 target genes in natural regulatory T cells.

Authors:  Timothy J Sadlon; Bridget G Wilkinson; Stephen Pederson; Cheryl Y Brown; Suzanne Bresatz; Tessa Gargett; Elizabeth L Melville; Kaimen Peng; Richard J D'Andrea; Gary G Glonek; Gregory J Goodall; Heddy Zola; M Frances Shannon; Simon C Barry
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

Review 6.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

7.  Eosinophils from hematopoietic stem cell recipients suppress allogeneic T cell proliferation.

Authors:  Jennie Andersson; Julia Cromvik; Madeleine Ingelsten; Christine Lingblom; Kerstin Andersson; Jan-Erik Johansson; Christine Wennerås
Journal:  Biol Blood Marrow Transplant       Date:  2014-08-28       Impact factor: 5.742

8.  Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study.

Authors:  B Giriens; P Yan; E Safroneeva; M Zwahlen; A Reinhard; A Nydegger; S Vavricka; C Sempoux; A Straumann; A M Schoepfer
Journal:  Allergy       Date:  2015-09-13       Impact factor: 13.146

9.  Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells.

Authors:  Guo-Yun Chen; Chong Chen; Lizhong Wang; Xing Chang; Pan Zheng; Yang Liu
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

10.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

View more
  6 in total

1.  Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features.

Authors:  Zachary M Dong; Edwin Lin; Michael E Wechsler; Peter F Weller; Amy D Klion; Bruce S Bochner; Don A Delker; Mark W Hazel; Keke Fairfax; Paneez Khoury; Praveen Akuthota; Peter A Merkel; Anne-Marie Dyer; Carol Langford; Ulrich Specks; Gerald J Gleich; Vernon M Chinchilli; Benjamin Raby; Mark Yandell; Frederic Clayton
Journal:  Am J Pathol       Date:  2020-04-03       Impact factor: 4.307

Review 2.  Alternative Splicing of FOXP3-Virtue and Vice.

Authors:  Reiner K W Mailer
Journal:  Front Immunol       Date:  2018-03-13       Impact factor: 7.561

3.  Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy.

Authors:  Benjamin L Wright; Nielsen Q Fernandez-Becker; Neeraja Kambham; Natasha Purington; Dana Tupa; Wenming Zhang; Matthew A Rank; Hirohito Kita; Kelly P Shim; Bryan J Bunning; Alfred D Doyle; Elizabeth A Jacobsen; Scott D Boyd; Mindy Tsai; Holden Maecker; Monali Manohar; Stephen J Galli; Kari C Nadeau; R Sharon Chinthrajah
Journal:  Front Immunol       Date:  2018-11-22       Impact factor: 7.561

4.  Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4.

Authors:  Viiu Paalme; Airi Rump; Kati Mädo; Marina Teras; Birgit Truumees; Helen Aitai; Kristel Ratas; Mickael Bourge; Chi-Shiun Chiang; Aram Ghalali; Thierry Tordjmann; Jüri Teras; Pierre Boudinot; Jean M Kanellopoulos; Sirje Rüütel Boudinot
Journal:  Front Immunol       Date:  2019-09-06       Impact factor: 7.561

5.  Patient-Reported Outcomes and Blood-Based Parameters Identify Response to Treatment in Eosinophilic Esophagitis.

Authors:  Christine Lingblom; Sofie Albinsson; Leif Johansson; Helen Larsson; Christine Wennerås
Journal:  Dig Dis Sci       Date:  2020-06-03       Impact factor: 3.199

6.  Kinetic studies of galectin-10 release from eosinophils exposed to proliferating T cells.

Authors:  C Lingblom; K Andersson; C Wennerås
Journal:  Clin Exp Immunol       Date:  2020-11-17       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.